347 related articles for article (PubMed ID: 27015567)
1. Medication adherence and the use of new pharmaceutical formulations: the case of levothyroxine.
Scavone C; Sportiello L; Cimmaruta D; Sullo MG; Vitelli B; Rafaniello C; Fossati T; Rossi F
Minerva Endocrinol; 2016 Jun; 41(2):279-89. PubMed ID: 27015567
[TBL] [Abstract][Full Text] [Related]
2. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
3. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study.
Ernst FR; Sandulli W; Elmor R; Welstead J; Sterman AB; Lavan M
Drugs R D; 2017 Mar; 17(1):103-115. PubMed ID: 27943146
[TBL] [Abstract][Full Text] [Related]
5. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.
Cappelli C; Pirola I; Daffini L; Formenti A; Iacobello C; Cristiano A; Gandossi E; Agabiti Rosei E; Castellano M
Thyroid; 2016 Feb; 26(2):197-202. PubMed ID: 26586610
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism.
Trimboli P; Mouly S
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743549
[TBL] [Abstract][Full Text] [Related]
7. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
[TBL] [Abstract][Full Text] [Related]
8. Serum thyrotropin levels following levothyroxine administration at breakfast.
Perez CL; Araki FS; Graf H; de Carvalho GA
Thyroid; 2013 Jul; 23(7):779-84. PubMed ID: 23363386
[TBL] [Abstract][Full Text] [Related]
9. Liquid and softgel levothyroxine use in clinical practice: state of the art.
Virili C; Trimboli P; Romanelli F; Centanni M
Endocrine; 2016 Oct; 54(1):3-14. PubMed ID: 27473098
[TBL] [Abstract][Full Text] [Related]
10. New Formulations of Levothyroxine in the Treatment of Hypothyroidism: Trick or Treat?
Nagy EV; Perros P; Papini E; Katko M; Hegedüs L
Thyroid; 2021 Feb; 31(2):193-201. PubMed ID: 33003978
[No Abstract] [Full Text] [Related]
11. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
12. Levothyroxine absorption in health and disease, and new therapeutic perspectives.
Ianiro G; Mangiola F; Di Rienzo TA; Bibbò S; Franceschi F; Greco AV; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2014; 18(4):451-6. PubMed ID: 24610609
[TBL] [Abstract][Full Text] [Related]
13. Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.
Lombardi CP; Bocale R; Barini A; Barini A; D'Amore A; Boscherini M; Bellantone R
Endocrine; 2017 Jan; 55(1):51-59. PubMed ID: 27388589
[TBL] [Abstract][Full Text] [Related]
14. Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli C; Pirola I; Gandossi E; Formenti A; Castellano M
Eur J Endocrinol; 2014 Jan; 170(1):95-9. PubMed ID: 24123095
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care.
Guglielmi V; Bellia A; Bianchini E; Medea G; Cricelli I; Sbraccia P; Lauro D; Cricelli C; Lapi F
Endocrine; 2018 Mar; 59(3):585-592. PubMed ID: 28905202
[TBL] [Abstract][Full Text] [Related]
16. Medication Adherence to Levothyroxine Therapy among Hypothyroid Patients and their Clinical Outcomes with Special Reference to Thyroid Function Parameters.
Shakya Shrestha S; Risal K; Shrestha R; Bhatta RD
Kathmandu Univ Med J (KUMJ); 2018; 16(62):129-137. PubMed ID: 30636753
[TBL] [Abstract][Full Text] [Related]
17. Are multisource levothyroxine sodium tablets marketed in Egypt interchangeable?
Abou-Taleb BA; Bondok M; Nounou MI; Khalafallah N; Khalil S
Ann Endocrinol (Paris); 2018 Feb; 79(1):23-29. PubMed ID: 29289332
[TBL] [Abstract][Full Text] [Related]
18. Hypothyroidism in adults. Levothyroxine if warranted by clinical and laboratory findings, not for simple TSH elevation.
Prescrire Int; 2015 Oct; 24(164):241-4, 246. PubMed ID: 26594730
[TBL] [Abstract][Full Text] [Related]
19. Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.
Benvenga S; Carlé A
Adv Ther; 2019 Sep; 36(Suppl 2):59-71. PubMed ID: 31485974
[TBL] [Abstract][Full Text] [Related]
20. Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis.
Hepp Z; Wyne K; Manthena SR; Wang S; Gossain V
Curr Med Res Opin; 2018 Sep; 34(9):1673-1678. PubMed ID: 29874941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
